FDA Inspection 1007462 — Neurotron. Inc.

Neurotron. Inc. — FEI 1121806

The FDA completed an inspection of Neurotron. Inc. on April 10, 2017 in Aurora, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 10, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Aurora, CO (United States)

Citations

IDCFRDescription
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
334521 CFR 820.200(a)Servicing - Lack of or inadequate procedures